Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026

世界のドラベ症候群治療薬市場2026:インサイト・予測

◆タイトル:Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11710
◆調査・発行会社:QYResearch
◆発行日:2020年11月
◆ページ数:98
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートはドラベ症候群治療薬の世界市場について調査・分析した資料です。種類別(BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他)の市場規模、用途別(クリニック、病院、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ドラベ症候群治療薬の競争状況、市場シェア
・世界のドラベ症候群治療薬市場:種類別市場規模 2015年-2020年(BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他)
・世界のドラベ症候群治療薬市場:種類別市場規模予測 2021年-2026年(BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他)
・世界のドラベ症候群治療薬市場:用途別市場規模 2015年-2020年(クリニック、病院、その他)
・世界のドラベ症候群治療薬市場:用途別市場規模予測 2021年-2026年(クリニック、病院、その他)
・北米のドラベ症候群治療薬市場分析:米国、カナダ
・ヨーロッパのドラベ症候群治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのドラベ症候群治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のドラベ症候群治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのドラベ症候群治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Biscayne Pharmaceuticals, Inc.、GW Pharmaceuticals Plc、INSYS Therapeutics, Inc.、OPKO Health, Inc.、PTC Therapeutics, Inc.、Sage Therapeutics, Inc.、Xenon Pharmaceuticals Inc.、Zogenix, Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market
The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Dravet Syndrome Thereapeutics Scope and Market Size
Dravet Syndrome Thereapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dravet Syndrome Thereapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Biscayne Pharmaceuticals, Inc.
GW Pharmaceuticals Plc
INSYS Therapeutics, Inc.
OPKO Health, Inc.
PTC Therapeutics, Inc.
Sage Therapeutics, Inc.
Xenon Pharmaceuticals Inc.
Zogenix, Inc.

Market segment by Type, the product can be split into
BIS-001
Cannabidiol
CUR-1916
SAGE-217
Others
Market segment by Application, split into
Clinic
Hospital
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dravet Syndrome Thereapeutics Revenue
1.4 Market by Type
1.4.1 Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 BIS-001
1.4.3 Cannabidiol
1.4.4 CUR-1916
1.4.5 SAGE-217
1.4.6 Others
1.5 Market by Application
1.5.1 Global Dravet Syndrome Thereapeutics Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Dravet Syndrome Thereapeutics Market Perspective (2015-2026)
2.2 Global Dravet Syndrome Thereapeutics Growth Trends by Regions
2.2.1 Dravet Syndrome Thereapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dravet Syndrome Thereapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dravet Syndrome Thereapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Dravet Syndrome Thereapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Dravet Syndrome Thereapeutics Players by Market Size
3.1.1 Global Top Dravet Syndrome Thereapeutics Players by Revenue (2015-2020)
3.1.2 Global Dravet Syndrome Thereapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Dravet Syndrome Thereapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dravet Syndrome Thereapeutics Market Concentration Ratio
3.2.1 Global Dravet Syndrome Thereapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Thereapeutics Revenue in 2019
3.3 Dravet Syndrome Thereapeutics Key Players Head office and Area Served
3.4 Key Players Dravet Syndrome Thereapeutics Product Solution and Service
3.5 Date of Enter into Dravet Syndrome Thereapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Dravet Syndrome Thereapeutics Historic Market Size by Type (2015-2020)
4.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)
5.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Dravet Syndrome Thereapeutics Market Size (2015-2020)
6.2 Dravet Syndrome Thereapeutics Key Players in North America (2019-2020)
6.3 North America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
6.4 North America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Dravet Syndrome Thereapeutics Market Size (2015-2020)
7.2 Dravet Syndrome Thereapeutics Key Players in Europe (2019-2020)
7.3 Europe Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
7.4 Europe Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

8 China
8.1 China Dravet Syndrome Thereapeutics Market Size (2015-2020)
8.2 Dravet Syndrome Thereapeutics Key Players in China (2019-2020)
8.3 China Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
8.4 China Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Dravet Syndrome Thereapeutics Market Size (2015-2020)
9.2 Dravet Syndrome Thereapeutics Key Players in Japan (2019-2020)
9.3 Japan Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
9.4 Japan Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Dravet Syndrome Thereapeutics Market Size (2015-2020)
10.2 Dravet Syndrome Thereapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

11 India
11.1 India Dravet Syndrome Thereapeutics Market Size (2015-2020)
11.2 Dravet Syndrome Thereapeutics Key Players in India (2019-2020)
11.3 India Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
11.4 India Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Dravet Syndrome Thereapeutics Market Size (2015-2020)
12.2 Dravet Syndrome Thereapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
12.4 Central & South America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Biscayne Pharmaceuticals, Inc.
13.1.1 Biscayne Pharmaceuticals, Inc. Company Details
13.1.2 Biscayne Pharmaceuticals, Inc. Business Overview
13.1.3 Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Introduction
13.1.4 Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020))
13.1.5 Biscayne Pharmaceuticals, Inc. Recent Development
13.2 GW Pharmaceuticals Plc
13.2.1 GW Pharmaceuticals Plc Company Details
13.2.2 GW Pharmaceuticals Plc Business Overview
13.2.3 GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Introduction
13.2.4 GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.2.5 GW Pharmaceuticals Plc Recent Development
13.3 INSYS Therapeutics, Inc.
13.3.1 INSYS Therapeutics, Inc. Company Details
13.3.2 INSYS Therapeutics, Inc. Business Overview
13.3.3 INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction
13.3.4 INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.3.5 INSYS Therapeutics, Inc. Recent Development
13.4 OPKO Health, Inc.
13.4.1 OPKO Health, Inc. Company Details
13.4.2 OPKO Health, Inc. Business Overview
13.4.3 OPKO Health, Inc. Dravet Syndrome Thereapeutics Introduction
13.4.4 OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.4.5 OPKO Health, Inc. Recent Development
13.5 PTC Therapeutics, Inc.
13.5.1 PTC Therapeutics, Inc. Company Details
13.5.2 PTC Therapeutics, Inc. Business Overview
13.5.3 PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction
13.5.4 PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.5.5 PTC Therapeutics, Inc. Recent Development
13.6 Sage Therapeutics, Inc.
13.6.1 Sage Therapeutics, Inc. Company Details
13.6.2 Sage Therapeutics, Inc. Business Overview
13.6.3 Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction
13.6.4 Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.6.5 Sage Therapeutics, Inc. Recent Development
13.7 Xenon Pharmaceuticals Inc.
13.7.1 Xenon Pharmaceuticals Inc. Company Details
13.7.2 Xenon Pharmaceuticals Inc. Business Overview
13.7.3 Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Introduction
13.7.4 Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.7.5 Xenon Pharmaceuticals Inc. Recent Development
13.8 Zogenix, Inc.
13.8.1 Zogenix, Inc. Company Details
13.8.2 Zogenix, Inc. Business Overview
13.8.3 Zogenix, Inc. Dravet Syndrome Thereapeutics Introduction
13.8.4 Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.8.5 Zogenix, Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Dravet Syndrome Thereapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Dravet Syndrome Thereapeutics Revenue
Table 3. Ranking of Global Top Dravet Syndrome Thereapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of BIS-001
Table 6. Key Players of Cannabidiol
Table 7. Key Players of CUR-1916
Table 8. Key Players of SAGE-217
Table 9. Key Players of Others
Table 10. Global Dravet Syndrome Thereapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Dravet Syndrome Thereapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Dravet Syndrome Thereapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Dravet Syndrome Thereapeutics Market Share by Regions (2015-2020)
Table 14. Global Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Dravet Syndrome Thereapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Dravet Syndrome Thereapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Dravet Syndrome Thereapeutics Players
Table 21. Global Dravet Syndrome Thereapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Dravet Syndrome Thereapeutics Market Share by Players (2015-2020)
Table 23. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2019)
Table 24. Global Dravet Syndrome Thereapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Dravet Syndrome Thereapeutics Product Solution and Service
Table 27. Date of Enter into Dravet Syndrome Thereapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Dravet Syndrome Thereapeutics Market Size Share by Type (2015-2020)
Table 31. Global Dravet Syndrome Thereapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Dravet Syndrome Thereapeutics Market Size Share by Application (2015-2020)
Table 33. Global Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Dravet Syndrome Thereapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 37. North America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 39. North America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 43. Europe Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 45. Europe Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 49. China Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 51. China Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 55. Japan Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 57. Japan Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 61. Southeast Asia Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 67. India Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 69. India Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 73. Central & South America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 77. Biscayne Pharmaceuticals, Inc. Company Details
Table 78. Biscayne Pharmaceuticals, Inc. Business Overview
Table 79. Biscayne Pharmaceuticals, Inc. Product
Table 80. Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 81. Biscayne Pharmaceuticals, Inc. Recent Development
Table 82. GW Pharmaceuticals Plc Company Details
Table 83. GW Pharmaceuticals Plc Business Overview
Table 84. GW Pharmaceuticals Plc Product
Table 85. GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 86. GW Pharmaceuticals Plc Recent Development
Table 87. INSYS Therapeutics, Inc. Company Details
Table 88. INSYS Therapeutics, Inc. Business Overview
Table 89. INSYS Therapeutics, Inc. Product
Table 90. INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 91. INSYS Therapeutics, Inc. Recent Development
Table 92. OPKO Health, Inc. Company Details
Table 93. OPKO Health, Inc. Business Overview
Table 94. OPKO Health, Inc. Product
Table 95. OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 96. OPKO Health, Inc. Recent Development
Table 97. PTC Therapeutics, Inc. Company Details
Table 98. PTC Therapeutics, Inc. Business Overview
Table 99. PTC Therapeutics, Inc. Product
Table 100. PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 101. PTC Therapeutics, Inc. Recent Development
Table 102. Sage Therapeutics, Inc. Company Details
Table 103. Sage Therapeutics, Inc. Business Overview
Table 104. Sage Therapeutics, Inc. Product
Table 105. Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 106. Sage Therapeutics, Inc. Recent Development
Table 107. Xenon Pharmaceuticals Inc. Company Details
Table 108. Xenon Pharmaceuticals Inc. Business Overview
Table 109. Xenon Pharmaceuticals Inc. Product
Table 110. Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 111. Xenon Pharmaceuticals Inc. Recent Development
Table 112. Zogenix, Inc. Business Overview
Table 113. Zogenix, Inc. Product
Table 114. Zogenix, Inc. Company Details
Table 115. Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 116. Zogenix, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dravet Syndrome Thereapeutics Market Share by Type: 2020 VS 2026
Figure 2. BIS-001 Features
Figure 3. Cannabidiol Features
Figure 4. CUR-1916 Features
Figure 5. SAGE-217 Features
Figure 6. Others Features
Figure 7. Global Dravet Syndrome Thereapeutics Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Dravet Syndrome Thereapeutics Report Years Considered
Figure 12. Global Dravet Syndrome Thereapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Dravet Syndrome Thereapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Dravet Syndrome Thereapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Dravet Syndrome Thereapeutics Market Share by Players in 2019
Figure 17. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Dravet Syndrome Thereapeutics Revenue in 2019
Figure 19. North America Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のドラベ症候群治療薬市場2026:インサイト・予測] (Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026 / QYR20NV11710)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆